ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 158

Quality of Referral Letters to Pediatric Rheumatology and Its Impact on Access to Care

Alexandra Rydz1,2, Fangfang Fu3, Mark Drew1, Dax Rumsey1,2, Yan Yuan1 and Mercedes Chan1,2, 1University of Alberta, Edmonton, AB, Canada, 2Stollery Children's Hospital, Edmonton, AB, Canada, 3Mathematical and Statistical Science, University of Alberta, Edmonton, AB, Canada

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Referrals and Triage

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Quality, Health Services and Education Research Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:

Delays in access to care in pediatric rheumatology (PR) are well known and may lead to significant morbidity. While barriers in accessing PR care are multifactorial, the literature suggests that incomplete referral letters may contribute to delays in subspecialist assessment. This study aims to describe the content of referral letters to PR at a tertiary care pediatric center, the impact of incomplete referral letters on time to PR assessment, and the proportion of referrals that resulted in a rheumatic diagnosis, all of which have yet to be described.

Methods:

All new referral letters to PR at our centre over an 8-month period were prospectively evaluated during weekly patient triage by 3 PR physicians. Using a validated referrals’ checklist, letters were reviewed for 8 components of a high-quality referral as outlined by hospital policy: rheumatic diagnosis of concern; patient symptoms; investigations; physical examination (mu­sculoskeletal and general); co-morbidities; current and past management; and medications. Referrals for patients >17 years old or previously followed by PR were excluded. Basic patient demographics and referring physician specialty were also collected.

Dates of triage decisions and resultant times to PR visits were recorded. Where incomplete referrals required additional information from referring physicians, we documented when this information was received and the resultant delay in triage time. Final diagnoses were recorded in retrospect.

Results:

Referrals (n=179, 63% female, median age 11.5 years) were received and analyzed from: family doctors (44%); pediatric providers, including subspecialists (43%); and others, e.g., pediatric ENT (13%). The frequency of specific components included in referral letters were: patient symptoms (94%); investigations (65%); diagnosis of concern (57%); medications (48%); musculoskeletal examination (46%); current and past management (41%); co-morbidities (34%); and general examination (27%).

Further information was requested from 33/179 (18%) referral letters regarding one or more of the following components: physical examination (91%); pertinent history (91%); diagnosis of concern (76%); and investigations (36%). Where missing information was requested, the median delay in time to triage was 1.3 weeks (IQR 0.1 – 2.3).

A final diagnosis was documented in 153 referrals, of which 53% had a confirmed rheumatic disease. The proportion of referrals resulting in a rheumatic diagnosis by provider was: 55% of those from pediatric providers; 51% from family doctors, and 52% from others. Referring physician specialty had no significant effect on the likelihood of a referral resulting in a rheumatic diagnosis.

Conclusion:

Pertinent history and physical examination were the most commonly omitted or inadequately described components of referral letters to PR. Requesting missing information resulted in delayed triage. Only about half of PR referrals from all referring physicians resulted in a rheumatic diagnosis. These findings can help guide medical education initiatives for referring physicians in their understanding of PR disease and facilitating access to timely PR care.


Disclosure: A. Rydz, 2; F. Fu, None; M. Drew, None; D. Rumsey, None; Y. Yuan, None; M. Chan, None.

To cite this abstract in AMA style:

Rydz A, Fu F, Drew M, Rumsey D, Yuan Y, Chan M. Quality of Referral Letters to Pediatric Rheumatology and Its Impact on Access to Care [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/quality-of-referral-letters-to-pediatric-rheumatology-and-its-impact-on-access-to-care/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-referral-letters-to-pediatric-rheumatology-and-its-impact-on-access-to-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology